Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from India-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from India

Published:2016 Issue:3 Volume:20 Page:372
ISSN:2230-8210
Container-title:Indian Journal of Endocrinology and Metabolism
language:en
Short-container-title:Indian J Endocr Metab

Author:

Prasanna Kumar KM,Mohan Viswanathan,Sethi Bipin,Gandhi Pramod,Bantwal Ganapathi,Xie John,Meininger Gary,Qiu Rong

Publisher

Medknow

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SGLT2 Inhibitors: Paradigm Shift from Diabetes Care to Metabolic Care—An Indian Perspective;Indian Journal of Endocrinology and Metabolism;2024-01

2. Prevalence of genitourinary infection in diabetic patients treated with SGLT 2 inhibitors;African Health Sciences;2023-04-06

3. Safety of sodium–glucose c otransporter 2 inhibitors in Asian type 2 diabetes populations;Journal of Diabetes Investigation;2022-10-19

4. Effect of Diabetes Distress and Self-care Activities on the Quality of Life of Type 2 Diabetic Patients: A Structural Equation Model;Jundishapur Journal of Chronic Disease Care;2022-02-04

5. SGLT 2 Inhibitors; glycemic control, weight loss and safety profile in patients with type 2 Diabetes, at Medicell Institute (MIDEM);Pakistan Journal of Medical Sciences;2020-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP